KZA 0.00% 8.0¢ kazia therapeutics limited

Excellent interim DIPG data from PNOC, page-17

  1. 83 Posts.
    lightbulb Created with Sketch. 19
    The results are definitely considerably superior to current standard of care. There is a path to approval. They have about $3.4M cash at the beginning of quarter equivalent to the burn in last quarter. Plus $500K US promissory note which could be converted to shares on Nov 17 or later there is cash at least this quarter end plus. Hope they do only a small raise at this price and look for a path of approval now. Fingers crossed right moves will be moved.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.